To include your compound in the COVID-19 Resource Center, submit it here.

FDA, Kaiser evaluating PROs in pancreatic cancer patients

FDA launched a study to explore patient-reported outcomes in patients with

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE